Download presentation
Presentation is loading. Please wait.
1
Infectious Mononucleosis & EBV Infection
Dave Rupar MD 3 April 2012
2
EBV- a herpesvirus Large, ds DNA
Identified in 1964 from Burkitt’s lymphoma tissue
3
EBV- a herpesvirus Ubiquitous
Problems for normal and immunocompromised hosts Latent infection Transformation of lymphocytes Oncogenic potential
4
Spread of EBV Spread by oral secretions 4-7 week incubation
Only 6% have identifiable contact Viral shedding by: 50-100% IM 25% asymptomatic seropositives 50% renal x-plant
5
Epidemiology of EBV 50% seroconversion by age 5
College students seroconvert 12%/year By age 25, 95% population is seropositive
6
A case, courtesy of HWC, MD “I am the man”
A 16 year old boy, star of the football team, comes to see you because of sore throat for 5 days with mild fatigue,
7
I am the man... PE: Fever 102 2+ AC nodes, no rash or jaundice
Red throat with marked tonsillar exudate abdomen benign
8
I am the man... LAB: Rapid strep test negative Monospot positive
9
Infectious Mononucleosis
Fever Pharyngitis Lymphadenopathy
10
Sumaya and Ench, Pediatrics 1985;75:1003
11
IM: other manifestations
Splenomegaly Hepatitis Rash Anemia Thrombocytopenia Encephalitis
12
IM: other manifestations
Splenomegaly Hepatitis Rash Anemia Thrombocytopenia Myocarditis Encephalitis By PE: 17% By U/S: >95% Average increase in size: 50% Rupture is rare but exciting
13
IM: other manifestations
Splenomegaly Hepatitis Rash Anemia Thrombocytopenia Encephalitis Hepatomegaly 10% Increased transaminases: 80% Rarely severe EBV not a cause of classic hepatitis
14
IM: other manifestations
Splenomegaly Hepatitis Rash Anemia Thrombocytopenia Encephalitis Ampicillin Other antibiotics
16
IM: other manifestations
Splenomegaly Hepatitis Rash Anemia Thrombocytopenia Encephalitis AIHA 0.5-3% Anti-i cold agglutinin Hemophagocytosis
17
IM: other manifestations
Splenomegaly Hepatitis Rash Anemia Thrombocytopenia Encephalitis 1-2 % of encephalitis Clinical picture not well established
18
IM: Diagnosis Clinical DDx GAS CMV “mono” Acute HIV syndrome
Adenovirus Toxoplasmosis Kawasaki disease Malignancy
19
Activated Cytotoxic T-lymphocytes =
IM: Lab Diagnosis Non-specific CBC LFT’s Activated Cytotoxic T-lymphocytes = “ Atypical Lymphs”
20
IM: Lab Diagnosis
21
Lab Diagnosis: Heterophile Ab
Paul & Bunnell, 1932: Serum from IM patients reacts with sheep blood Monospot uses horse rbc’s IgM polyclonal Ab Does not react with EBV antigens PPV 95% for EBV in patients with consistent illness
22
Lab Diagnosis: Heterophile Ab
False negatives Too early (days-weeks) Too young (<4 yo) Heterophile neg mono: CMV, HIV, hep B, toxo. False positives HPV B19, CMV, other viruses SLE Sarcoid Lymphoma
23
Heterophile tests vary with age
24
EBV-specific Serology
25
EBV-specific Serology
Positive VCA IgM Positive VCA IgG, negative EBNA = ? Positive VCA IgG Positive EBNA, negative VCA IgM =? All negative =?
26
What can you learn from EBV serology?
Recent infection - positive VCA IgM & IgG, negative EBNA, variable EA Old infection - positive VCA IgG and EBNA, negative VCA IgM Never infected - all negative Do Not overinterpret- much variation in patterns Beware of “chronic infection” or “reactivation”
27
Detection of Virus: PCR
Primarily a research tool Clinical application in PTLD, severely immunosuppressed patients No standardization for use in mono syndromes
28
The natural history of mono
Rea et al. JABFP 2001;14:234 150 patients with IM, mean age 21+7
29
Labs quickly return to normal
Rea et al. JABFP 2001;14:234 150 patients with IM, mean age 21+7
30
Back to the case: You know that the most common serious complications are… 1. Airway obstruction 2. Splenic rupture 3. Liver failure 4. Lymphoproliferative disease 5. 1 and 2
31
I am the man... 6 days after first visit (11days into illness),
Dad (an MD) says son is well and wants to play football now At recheck that day, he is well and has nl PE Should you let him play?
32
Complications after IM
Splenic rupture Airway Obstruction Fatigue
33
Complications after IM
Splenic rupture Fatigue Airway Obstruction Spontaneous rupture 0.1% 40 years at Mayo 8116 IM 5 definite, 4 probable LUQ pain Consider non-op mgmt Mayo Clin Proceed 1992;67:846
34
How soon can he safely return to sports after his mono?
1. 3 weeks 2. 4 weeks 3. 5 weeks 4. 6 weeks 5. 6 months
35
How to decide?
36
Clinical algorithm: Return to play
Auwater P. Infectious mononucleosis: Return to play. Clinics in Sports Medicine 2004; 23:485. Thanks, Dr Henin
37
What about the Athlete? Part Deux
“Contact Sports should be avoided until the patient is recovered fully from IM and the spleen is no longer palpable.” 2009 Red Book, p 292
38
Complications after IM
Splenic rupture Airway Obstruction Fatigue
39
Acute Airway Obstruction
Little data Rare (<1%?) More common in young children? Look for stridor, dyspnea Monitor O2 sats Steroids may be helpful in hospitalized patient
40
Complications after IM
Splenic rupture Airway Obstruction Fatigue
41
Complications after IM
Splenic rupture Airway Obstruction Fatigue Generally “2-4 week” duration 1948: 25% persistent illness with fatigue at 3 mo. 2001: 2 mo- 38% not recovered 6 mo- 12% not recovered
42
Disease Profile in Male and Female Case Patients with Infectious Mononucleosis.
Macsween K F et al. Clin Infect Dis. 2010;50: © 2010 by the Infectious Diseases Society of America
43
“Chronic Mono”? Fatigue after IM is common
Female sex, premorbid personality are risk factors No evidence of ongoing viral replication or organ involvement Prognosis is excellent Encourage activity
44
Chronic Fatigue Syndrome
Fatigue is common in the adolescent/young adult population More common after IM than other infections Much is unexplained “Abnormal” EBV AB no more common in CFS than in general population “Necessary but insufficient”? Don’t blame Lyme, either
45
Contrast “Chronic Mono” with
Severe Chronic Active EBV Infection X-linked Lymphoproliferative Syndrome Virus-Associated Hemophagocytic Syndrome
46
EBV: treatment Supportive only in most cases
Acyclovir, etc. of limited value Widespread belief in value of steroids despite suspicion of increased serious complications Role for prednisone (1 mg/kg) in UAO Hemolytic anemia Myocarditis HPS
47
Does treatment work? C: Time away from school/work A: Duration of ST
94 patients, mean age 18, with IM. Randomized, DB, PC Acyclovir + prednisone vs placebo. All results NS Tynell et al. J Infect Dis 1996;174:324
48
EBV: treatment “Although therapy with short-course corticosteroids may have a beneficial effect on acute symptoms, because of potential adverse effects, their use should be considered only for patients with impending airway obstruction, massive splenomegaly, myocarditis, hemolyic anemia or HLH.” Emphasis added. 2009 Red Book, page 292
49
Don’t forget to fill out your pathogen brackets!
The End ? Don’t forget to fill out your pathogen brackets!
50
SCAEBV >6 months duration Fever Lymphadenopathy HSM Pancytopenia
Often fatal High VCA IgG High EA IgG EBV DNA in tissue, blood No HPS Organ involvement BM Lungs Hepatitis Uveitis
51
Hemophagocytic Syndrome
Median age ~18 months Primary (HLH) vs. secondary (VAHPS) EBV one of identified causes High fatality FUO HSM Lymphadenopathy Rash Pneumonia DIC Clin Infect Dis 2003;36:306
52
Hemophagocytic Syndrome
Pancytopenia (>2 cell lines) Elevated LFT’s, LDH Coagulopathy Hyperferritinemia HP in BM, spleen, nodes
53
IM: Encephalitis CEP: 17 patients with encephalitis due to EBV
Median age 11 (1-31) 11 ICU 14 fever 11 seizure 4 coma CSF 7 wbc ((0-2250) Pro 37 (21-139) Glucose normal
54
XLP Young males Severe, fatal IM May have IAHPS Hypogammaglobulin-emia
NHL Genetic Diagnosis Family History
55
Graph showing correlation of initial fatigue score with the duration of fatigue (P=.023).
Macsween K F et al. Clin Infect Dis. 2010;50: © 2010 by the Infectious Diseases Society of America
56
EBV- associated malignancies
Burkitt’s lymphoma (African children) NP carcinoma CNS lymphoma in AIDS patients Hodgkin’s lymphoma
57
EBV- a herpesvirus Binds to CD21 receptor (B-lymphocytes)
Up to 20% infected acutely Most cleared 50/109 remain latently infected (episome) Express only 10 genes Lifelong reservoir
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.